1. CCR6-CCL20 axis as a therapeutic target for autoimmune diseases
    Heikrujam Thoihen Meitei et al, 2021, Autoimmunity Reviews CrossRef
  2. Small molecule inhibitors of RORĪ³t for Th17 regulation in inflammatory and autoimmune diseases
    Jiuping Zeng et al, 2023, Journal of Pharmaceutical Analysis CrossRef
  3. The Increased Expression of CCL20 and CCR6 in Rectal Mucosa Correlated to Severe Inflammation in Pediatric Ulcerative Colitis
    Keiichi Uchida et al, 2015, Gastroenterology Research and Practice CrossRef
  4. Role of chemokine receptors and intestinal epithelial cells in the mucosal inflammation and tolerance
    Neeraja Kulkarni et al, 2017, Journal of Leukocyte Biology CrossRef
  5. VPR-254: an inhibitor of ROR-gamma T with potential utility for the treatment of inflammatory bowel disease
    Leo R. Fitzpatrick et al, 2020, Inflammopharmacology CrossRef
  6. SMAD4 Suppresses Colitis-associated Carcinoma Through Inhibition of CCL20/CCR6-mediated Inflammation
    David N. Hanna et al, 2022, Gastroenterology CrossRef
  7. The involvement of TH17 cells in the pathogenesis of IBD
    Ping Jiang et al, 2023, Cytokine & Growth Factor Reviews CrossRef
  8. Deregulation of SGK1 in Ulcerative Colitis: A Paradoxical Relationship Between Immune Cells and Colonic Epithelial Cells
    Rocco Spagnuolo et al, 2018, Inflammatory Bowel Diseases CrossRef
  9. The crucial role of fish mucus in regulating progeny inflammation and microbial homeostasis
    Zi-Xuan Wang et al, 2024, Water Biology and Security CrossRef